2025-01-31 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**1. Performance Relative to S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits programs and services.  The cumulative return of UNH is 151.63%, significantly outperforming the S&P 500's cumulative return of 121.09%.  The difference is 30.5%, placing it in the 24.8th percentile of its historical performance relative to the S&P 500 based on provided data (max difference of 135.7%, min difference of -4.2%).

**Alpha/Beta Analysis:**  The provided data shows consistently positive alpha values (0.1), suggesting UNH has outperformed the market (as represented by the S&P 500).  The beta values generally hover around 1, indicating a similar level of volatility compared to the market. However, the recent period (2022-2025) shows negative CAGR and significantly high MDD, highlighting higher risk during this period.


**2. Recent Price Movement:**

* **Closing Price:** $545.57
* **5-Day Moving Average:** $540.44
* **20-Day Moving Average:** $526.09
* **60-Day Moving Average:** $550.94

The stock price is slightly below its 60-day moving average, suggesting potential downward pressure. However, it is above both its 5-day and 20-day moving averages, indicating short-term upward momentum.  The recent price increase of $1.39 (from the previous close) reflects a positive short-term trend.


**3. Technical Indicators and Expected Return:**

* **RSI (58.92):** Indicates the stock is neither overbought nor oversold, suggesting a neutral sentiment.
* **PPO (0.74):** A positive PPO suggests bullish momentum.
* **20-Day Relative Strength Change (+6.4):** Shows a recent increase in relative strength, supporting the short-term upward trend.
* **Expected Return (237.8%):** This represents a significant projected excess return compared to the S&P 500 over the long term (2+ years) through consistent investment.


**4. Recent Earnings Analysis:**

The earnings data shows some volatility. While Q4 2024 and Q4 2023 EPS were strong (6.56 and 6.31 respectively), Q2 2024 showed a substantial decline to 4.58 and a negative EPS in Q1 2024 (-1.53).  Revenue has generally increased quarter-over-quarter, with minor fluctuations. Further investigation into the reasons behind the Q1 2024 EPS loss is recommended.  The duplicate entry for 2024-11-04 needs clarification.


**5. Financial Information:**

* **Revenue and Profitability:** Revenue remains relatively stable and high. Profit margins fluctuated in a narrow range, mostly above 20%, except for a small dip in Q1 2024.  The recent quarter shows a slight decrease in profitability compared to the previous year.

* **Capital and Profitability:** Equity shows a general upward trend.  ROE fluctuates significantly, indicating varied profitability throughout the observed period.  A negative ROE in Q1 2024 mirrors the negative EPS, requiring further scrutiny.


**7. Overall Analysis:**

UNH has shown strong long-term performance exceeding the S&P 500.  Technical indicators suggest a neutral to slightly bullish short-term outlook.  However, recent earnings show some volatility, with a notable negative EPS in Q1 2024.  The projected long-term expected return is very high but needs to be considered cautiously alongside the observed fluctuations in profitability and the recent negative CAGR in the provided alpha/beta analysis.   Further investigation into the causes of the Q1 2024 loss and the duplication in the November 2024 earnings data is necessary.  A thorough analysis of the company's strategy, competitive landscape, and future growth prospects is crucial before making investment decisions.  The high projected return should be interpreted with caution, recognizing the potential for significant risk as indicated by recent high maximum drawdowns (MDD).


**8. Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice.  Independent research and consultation with a financial professional are recommended before making any investment decisions.
